Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Business Exposures Activism Animal Testing Artificial Intelligence Boeing 737 Brexit Cannabis Censorship Climate Coal COVID-19 Criminal Death Debt Markets Derivatives Diversity Economy Electric Vehicles Electricity Generation Ethanol Financial Firearms Fossil Fuels Glyphosate Harassement Immigration Information Security Intellectual Property Interest Rates Labor Layoff Lead Legal Palm Oil Pension Political Product Safety Regulatory Religion Securities Market Supply Chain Tariff Textiles US Equities < Previous 1 2 3 4 5 6 7 8 9 ... 99 100 Next > Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years September 25, 2024 Via Benzinga Exposures Product Safety Tickers LLY MRK Florida Cannabis Ballot: NFL's Ricky Williams Backs Legalization, New Ad 'Hypocrisy Of Alcohol Vs. Marijuana' September 24, 2024 Via Benzinga Topics Cannabis Exposures Cannabis Product Safety Creative Biolabs: Lock and Load with Next-Gen mRNA Tech September 24, 2024 Via Get News Topics Death Exposures COVID-19 Death Product Safety Clene Inc. (NASDAQ: CLNN) to Discuss Lead Candidate CNM-Au8(R) Biomarker, Clinical Data for ALS with Food and Drug Administration Leadership September 24, 2024 Via Investor Brand Network Exposures Product Safety Tickers CLNN As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse September 24, 2024 Via FinancialNewsMedia Exposures Product Safety Tickers AMRX LLY NTRB NTRBW RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU announced September 24, 2024 Via PR Leap Exposures Product Safety Graphic Cabin™ by Hatfield Creative: Your Local Partner for Custom Beverage Labels, Wall Decals, and Trade Show Displays September 23, 2024 Via Syndication Cloud Exposures Product Safety Cybersecurity for Medical Devices: 4 Ways to Remain Compliant September 23, 2024 Via Syndication Cloud Exposures Product Safety Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles September 23, 2024 Via Benzinga Topics Product Recall Exposures COVID-19 Legal Product Safety Tickers GILD New Study Warns of High Dose "ADHD" Drugs Inducing Psychosis September 23, 2024 Via PRLog Exposures Product Safety Biohaven Stock Spikes After Drug Candidate To Treat Rare Neurodegenerative Disease Shows Promise September 23, 2024 Via Benzinga Exposures Product Safety Tickers BHVN InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Participate in Global Conference with Three TNX-102 SL Data Presentations September 23, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers TNXP Sanofi's Sarclisa Secures FDA Approval For First-Line Multiple Myeloma, Marking Its Third US Approval September 23, 2024 Via Benzinga Exposures Product Safety Tickers SNY BOQU Instrument Elevates Professional Standards in Water Quality Sensors and Analyzers September 20, 2024 Via AB Newswire Topics Intellectual Property Supply Chain Exposures Intellectual Property Product Safety Supply Chain Approved for Domestic Market, OT-1001 Ushers in a New Era for Pediatric Allergic Conjunctivitis Treatment September 20, 2024 Via AB Newswire Exposures Product Safety Burning Daily Announces Enhanced Brand Selection Standards to Ensure Premium Products for Customers. September 20, 2024 Via GetFeatured Topics Supply Chain Exposures Product Safety Supply Chain ICU Medical Recalls ParaPAC Plus Ventilators Due To Loose Outlet Connector That Can Cause Injury Or Death September 20, 2024 Via Benzinga Topics Product Recall Exposures Legal Product Safety Tickers ICUI Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years September 20, 2024 Via Benzinga Exposures Product Safety Tickers ABBV BMY Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients September 20, 2024 Via Benzinga Exposures Product Safety Tickers JNJ Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease September 20, 2024 Via Benzinga Exposures Product Safety Tickers JNJ ZVRA Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy September 20, 2024 Via Benzinga Exposures Product Safety Tickers ELAN ZTS GM To Recall Nearly 450K Vehicles Over Inoperative Warning Lights On Loss Of Brake Fluid September 20, 2024 Via Benzinga Topics Product Recall Exposures Legal Product Safety Tickers GM ICU Medical Recalls Certain Tracheostomy Tubes Due To Manufacturing Defects September 19, 2024 Via Benzinga Topics Product Recall Exposures Legal Product Safety Tickers ICUI BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Awarded Patent Covering Intranasal Delivery of FDA-Approved Tosymra to Treat Migraines September 19, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers TNXP FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies September 19, 2024 Via Benzinga Exposures Product Safety Tickers VNDA Robert Kennedy Jr: Trump Wants Him To Help Pick CDC, FDA, and NIH Leaders — 'Unravel The Capture Of Agencies By Corrupt Influence' September 18, 2024 Via Benzinga Topics Government Exposures Political Product Safety Flipping the Script on LBPs: Creative Biolabs Delivers Game-Changing Analytical Services September 18, 2024 Via Get News Exposures Product Safety Zimmer Biomet To Stop Selling CPT Hip Implant System By End Of 2024 Due To High Fracture Risks September 18, 2024 Via Benzinga Exposures Product Safety Tickers ZBH Merck's Keytruda Secures First FDA-Approval For Rare Form Aggressive Cancer September 18, 2024 Via Benzinga Exposures Product Safety Tickers MRK AstraZeneca's Asthma Drug Gets FDA Approval For Rare Disease Of Blood Vessel Inflammation September 18, 2024 Via Benzinga Exposures Product Safety Tickers AZN GSK < Previous 1 2 3 4 5 6 7 8 9 ... 99 100 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.